BioSpace News Archive

Eli Lilly and Company (NYSE: LLY) will now conduct its second-quarter 2022 financial results investor conference call today at 10 a.m. Eastern time due to third-party technical difficulties.

Last year, US Capital Global Securities LLC launched a convertible note offering of up to $30 million for QT Imaging, Inc., an innovative MedTech company that continues to reach new milestones in product development, testing, and clearance.

Viome Life Sciences, a mission-driven biotechnology company, announces the arrival of its CancerDetect™ test for oral & throat cancer, the first to launch in a series of diagnostic tests in development.

BioAesthetics Corporation today announced an additional clinical study for the BioAesthetics® NACgraft™ Acellular Allograft that will investigate its performance in subpopulations of breast cancer survivors and other individuals needing nipple reconstruction.

AnHeart Therapeutics announced it will host an investigator meeting in addition to a e-poster presentation at the World Conference on Lung Cancer in Vienna, Austria at 11:00 am ET on Sunday, Aug. 7, 2022.

Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to provide the following update for Its AcuVid™ COVID-19 Rapid Antigen Saliva Test.

Adaptimmune Therapeutics plc (NASDAQ: ADAP), a leader in cell therapy to treat cancer, today reported financial results for the second quarter ended June 30, 2022 and provided a business update.

SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today it will host its first-ever Investor Day on Tuesday, September 20, 2022, at PUBLIC Hotel in New York City.

Halberd Corporation (OTC Pink: HALB) has received a letter of endorsement from Carl Eller, President of the NFL Retired Players Association (NFL RPA), for Halberd’s research work in the development of treatments for Traumatic Brain Injury (TBI)/chronic traumatic encephalopathy (CTE) sustained by current and retired players.

Spineology Inc., the longtime leader in ultra-minimally invasive spine surgery, announces another milestone today with the limited launch of OptiLIF® Endo.